Important Notices

Baxter International Inc. announced on Aug. 25, 2026, a voluntary nationwide recall of 0.9% Sodium Chloride Injection 500mL VIAFLEX Plastic Container.

On Aug. 21, 2026, Vitruvias Therapeutics, Inc. initiated a voluntary recall for one lot of Thyroid Tablets, USP 30mg.

Biotest AG initiated a voluntary withdrawal for certain lots of Yimmugo® (immune globulin IV, human-dira), 10% liquid, on Aug. 13, 2026.

On Aug. 12, 2026, Grifols Therapeutics initiated a voluntary withdrawal of one lot of Gamunex®-C (immune globulin injection [human], 10%), 40g/400mL vial.

On Aug. 11, 2026, Grifols Therapeutics initiated a voluntary withdrawal of one lot of Gammaked™ (immune globulin injection [human], 10%), 20g.

On Aug. 10, 2026, Fresenius Kabi initiated a voluntary recall of Tyenne® (tocilizumab-aazg) Injection, 400mg/20mL (20mg/mL), 20mL vials.

On Aug. 7, 2026, Baxter Healthcare Corporation initiated a voluntary recall of selected lots of Myxredlin® (insulin human), Cardene IV® (nicardipine hydrochloride), Nexterone® (amiodarone HCl), and multiple injectable famotidine, clindamycin, dexmedetomidine, vasopressin, vancomycin, pantoprazole, and daptomycin products

On Aug. 4, 2026, Fresenius Kabi initiated a nationwide voluntary recall of one lot of Morphine Sulfate Injection

On July 30, 2026, GC Biopharma Corporation initiated a voluntary market withdrawal for three lots of Alyglo® (immune globulin intravenous, human-stwk) 10% Liquid.

On July 24, 2026, Baxter International Inc. initiated a voluntary recall of cefazolin in dextrose injection, USP, 2g/100mL (20mg/mL), single-dose infusion bag, 100mL.